![]() |
|
|
Vol. 291, Issue 3, 1164-1171, December 1999
1-Adrenergic Receptor Function by Benzodiazepines: A
Potential Site of Allosteric Modulation1
Departments of Molecular Cardiology (D.J.J.W., R.J.G.,
D.M.P.) and Anesthesiology Research (D.S.D., P.A.M.), The Lerner
Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio
Benzodiazepines, a class of drugs commonly used to induce anesthesia
and sedation, can attenuate intracellular calcium oscillations evoked
by
1-adrenergic receptor (
1-AR)
stimulation in pulmonary artery smooth muscle cells. We postulated a
direct action of benzodiazepines in modulating
1-AR
function at the receptor level. Benzodiazepines bound to each of the
cloned
1-AR subtypes (
1a-,
1b-, or
1d-AR) on COS-1 cell membranes
transiently transfected to express a single population of
1-AR subtype. The ability of benzodiazepines to alter
1-AR signal transduction was investigated by measuring total inositol phosphate generation in rat-1 fibroblast cells, stably
transfected to express a single
1-AR subtype. By
themselves, benzodiazepines displayed partial agonism. At
1b-ARs and
1d-ARs, the maximal inositol
phosphate response to phenylephrine was potentiated almost 2-fold by
either midazolam or lorazepam (100 µM). At
1a-ARs, diazepam, lorazepam, and midazolam all increased the maximal response of the partial agonist clonidine at these receptors, whereas the response to the full agonist phenylephrine was unaltered or inhibited. The potentiating actions of midazolam and its partial agonism at
1-ARs was blocked by the addition of 1 µM prazosin, an
1-AR antagonist, and not by a
-aminobutyric
acidA-receptor antagonist. These studies show that
benzodiazepines modulate the function of
1-ARs in vitro,
and this is the first report of a potential allosteric site on
1-ARs that may be therapeutically useful for drug design.
This article has been cited by other articles:
![]() |
A. J. Copik, C. Ma, A. Kosaka, S. Sahdeo, A. Trane, H. Ho, P. S. Dietrich, H. Yu, A. P. D. W. Ford, D. Button, et al. Facilitatory Interplay in {alpha}1a and {beta}2 Adrenoceptor Function Reveals a Non-Gq Signaling Mode: Implications for Diversification of Intracellular Signal Transduction Mol. Pharmacol., March 1, 2009; 75(3): 713 - 728. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Freo, M. Dam, and C. Ori The Time-Dependent Effects of Midazolam on Regional Cerebral Glucose Metabolism in Rats Anesth. Analg., May 1, 2008; 106(5): 1516 - 1523. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yamamoto, J. Yamada, S. Ueno, H. Kubota, T. Furukawa, S. Yamamoto, and A. Fukuda Insertion of {alpha}7 Nicotinic Receptors at Neocortical Layer V GABAergic Synapses Is Induced by a Benzodiazepine, Midazolam Cereb Cortex, March 1, 2007; 17(3): 653 - 660. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Chen, G. Rogge, C. Hague, D. Alewood, B. Colless, R. J. Lewis, and K. P. Minneman Subtype-selective Noncompetitive or Competitive Inhibition of Human {alpha}1-Adrenergic Receptors by {rho}-TIA J. Biol. Chem., August 20, 2004; 279(34): 35326 - 35333. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. A. Sharpe, L. Thomas, M. Loughnan, L. Motin, E. Palant, D. E. Croker, D. Alewood, S. Chen, R. M. Graham, P. F. Alewood, et al. Allosteric {alpha}1-Adrenoreceptor Antagonism by the Conopeptide {rho}-TIA J. Biol. Chem., September 5, 2003; 278(36): 34451 - 34457. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Christopoulos and T. Kenakin G Protein-Coupled Receptor Allosterism and Complexing Pharmacol. Rev., June 1, 2002; 54(2): 323 - 374. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ellis and M. Seidenberg Interactions of Alcuronium, TMB-8, and Other Allosteric Ligands with Muscarinic Acetylcholine Receptors: Studies with Chimeric Receptors Mol. Pharmacol., April 13, 2001; 58(6): 1451 - 1460. [Abstract] [Full Text] |
||||
![]() |
R. A. Leppik and N. J. M. Birdsall Agonist Binding and Function at the Human alpha 2A-Adrenoceptor: Allosteric Modulation by Amilorides Mol. Pharmacol., November 1, 2000; 58(5): 1091 - 1099. [Abstract] [Full Text] |
||||